|Articles|January 1, 2001

January 2001
Volume 7
Issue 1

Disenrollment from Medicare HMOs

Author(s)Kathleen Tiede Call, PhD, Bryan E. Dowd, PhD, Roger Feldman, PhD

Download PDF: Disenrollment from Medicare HMOs

Articles in this issue

over 25 years ago

Article

Indirect Cost of Ischemic Heart Disease to Employers

over 25 years ago

Article

A Comparison of Abciximab Use in MCO and Non-MCO Populations

over 25 years ago

Article

Drugs and the Elderly, Part 2: Strategies for Improving Prescribing in a Managed Care Environment

over 25 years ago

Article

Ambulatory Drug Utilization Review: Opportunities for Improved Prescription Drug Use

over 25 years ago

Article

The Employer's Perspective

over 25 years ago

Article

Can Administrative Database Studies Inform Medication Use Policy Decisions? An Application of Occam's Razor

over 25 years ago

Article

Is the Healthcare Workforce a Barrier to Cost Containment?

over 25 years ago

Article

Is the Healthcare Workforce a Barrier to Cost Containment?

over 25 years ago

Article

Is the Healthcare Workforce a Barrier to Cost Containment?

over 25 years ago

Article

Is the Healthcare Workforce a Barrier to Cost Containment?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Disenrollment from Medicare HMOs

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access